Virtu Financial’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Virtu Financial’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,228	Closed	-$666K	–	2284
2020 Q4	$666K	Buy	+30,228	New	+$666K	0.07%	357
2018 Q4	–	Sell	-25,184	Closed	-$384K	–	2135
2018 Q3	$384K	Buy	+25,184	New	+$367K	0.02%	715
2018 Q2	–	Sell	-14,416	Closed	-$138K	–	2671
2018 Q1	$138K	Buy	+14,416	New	+$155K	0.01%	1490
2017 Q4	–	Sell	-19,861	Closed	-$114K	–	3226
2017 Q3	$114K	Buy	+19,861	New	+$72.3K	0.01%	2040

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Virtu Financial's DRNA Position: Q1 2021 in Review

Virtu Financial sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q1 2021, closing a stake of 30,228 shares — an estimated $666K sold.

Virtu Financial first reported a position in DRNA in Q3 2017 and held it in 4 quarters. The position peaked at $666K in Q4 2020. 183 funds tracked by Wall St. Rank hold DRNA as of Q1 2021.

Virtu Financial reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Virtu Financial sold 30,228 Dicerna Pharmaceuticals, Inc. shares in Q1 2021, an estimated $666K.
Virtu Financial first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2017 and held it in 4 quarters.
Virtu Financial's Dicerna Pharmaceuticals, Inc. position peaked at $666K in Q4 2020.
183 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.